Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)

Sponsor and Collaborators
Samsung Medical Center

Contact
Kyu-Sung Lee, PhD
82-2-3410-3554
ksleedr@skku.edu

Principal Investigator
Kyu-Sung Lee, PhD
Samsung Medical Center

ClinicalTrials.gov Identifier
NCT00922506
You must be a registered member of RUN to post a comment.

Sign Up for Free e-newsletters